Melanoma Recurrence Risk Factors: Breslow, Ulceration, Nodal Status & More

Risk of melanoma recurrence is stratified by clinicopathologic features. The AJCC 8th edition staging system incorporates these factors.

Primary Tumor Factors

• Breslow thickness: strongest predictor; >4 mm = high risk.
• Ulceration: upstages T category; indicates aggressive biology.
• Mitotic rate: ≥1/mm² (especially ≥5) worsens prognosis.
• Lymphovascular invasion (LVI): correlates with nodal/distant spread.
• Histologic subtype: desmoplastic, acral, mucosal have distinct patterns.
• BRAF V600 mutation: associated with higher proliferative rate; targeted therapy implications.

Regional Nodal Factors

• Sentinel lymph node biopsy (SLNB) status: positive → stage III.
• Number of positive nodes: 1 vs. ≥4 (N1–N3).
• Nodal tumor burden: micrometastasis (<0.1 mm) vs. macrometastasis; extracapsular extension.

Distant Metastasis (Stage IV)

• M1a: skin/subcutaneous/ distant nodes
• M1b: lung
• M1c: other visceral
• M1d: CNS
• LDH elevation upstages to M1c/d.

Host Factors

• Age: younger patients have higher recurrence rates (more aggressive biology).
• Sex: male sex independently associated with worse survival.
• Immunosuppression: iatrogenic or HIV increases risk.

Surveillance

NCCN guidelines: history/skin exam q3–6 mo × 2 yr, then q6–12 mo; imaging (CT/PET‑CT) for stage IIB–IV or symptomatic.